SINGAPORE, Nov. 29, 2024 /PRNewswire/ -- CBC Group ("CBC"), Asia's largest healthcare-dedicated asset management firm headquartered in Singapore, has completed the strategic acquisition of global ...
UCB SA is divesting its mature neurology and allergy business in China, selling those products to CBC Group and Mubadala Investment Co. for $680 million so it can refocus on innovation and ...
European biopharmaceutical company UCB SA (OTC:UCBJF) (OTC:UCBJY) announced a $680 million strategic divestment deal in China. The transaction involves the sale, divestment, and license of UCB’s ...
UCB announced plans to divest its entire current China five-drug portfolio, narrowing its China focus to commercialize soon-to-arrive late-stage clinical assets. YolTech Therapeutics sold China rights ...
PARIS/SINGAPORE, Aug 26 (Reuters) - UCB (UCB.BR), opens new tab, a Belgian biopharmaceutical firm, said on Monday it would sell its Chinese neurology and allergy business to Singapore-based asset ...
PARIS/SINGAPORE (Reuters) -UCB, a Belgian biopharmaceutical firm, said on Monday it would sell its Chinese neurology and allergy business to Singapore-based asset management group CBC and Abu Dhabi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results